Somerset Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,186
Closed -$243K 72
2022
Q1
$243K Hold
2,186
0.17% 69
2021
Q4
$226K Hold
2,186
0.15% 75
2021
Q3
$274K Hold
2,186
0.2% 64
2021
Q2
$271K Hold
2,186
0.19% 65
2021
Q1
$258K Hold
2,186
0.19% 68
2020
Q4
$256K Hold
2,186
0.2% 64
2020
Q3
$227K Hold
2,186
0.21% 60
2020
Q2
$200K Buy
+2,186
New +$210K 0.2% 62
2020
Q1
Sell
-2,186
Closed -$248K 64
2019
Q4
$248K Buy
+2,186
New +$240K 0.22% 60

Other funds holding MDT

Somerset Group's MDT Position: Q2 2022 in Review

Somerset Group sold out of Medtronic (MDT) in Q2 2022, closing a stake of 2,186 shares — an estimated $243K sold.

Somerset Group first reported a position in MDT in Q4 2019 and held it in 9 quarters. The position peaked at $274K in Q3 2021. 2,021 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Somerset Group reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
  • Somerset Group sold 2,186 Medtronic shares in Q2 2022, an estimated $243K.
  • Somerset Group first reported a position in Medtronic in Q4 2019 and held it in 9 quarters.
  • Somerset Group's Medtronic position peaked at $274K in Q3 2021.
  • 2,021 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Somerset Group's 13F filing for Q2 2022, filed 10 Aug 2022.